Oncternal Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	28	20	25	27	-
Market Cap Growth	4.60%	-21.84%	-6.40%	-	-
Enterprise Value	28	19	24	24	-
Last Close Price	0.36	0.30	0.51	0.72	-
PB Ratio	15.78	8.45	2.44	4.04	-
P/TBV Ratio	15.78	8.45	2.44	4.04	-
EV/EBITDA Ratio	-	6.13	-	-	-
Quick Ratio	4.33	9.08	2.71	575.72	4.46
Current Ratio	4.33	9.50	4.00	617.43	5.30
Return on Equity (ROE)	-206.07%	-188.61%	-61.12%	-64.14%	-
Return on Assets (ROA)	-44.73%	-43.02%	-36.90%	-38.11%	-
Return on Capital (ROIC)	-45.93%	-44.71%	-37.78%	-38.66%	-
Earnings Yield	-41.23%	-60.64%	-20.63%	-8.43%	-
FCF Yield	-10.41%	-16.70%	-18.44%	-5.08%	-
Buyback Yield / Dilution	-28.59%	-26.14%	-46.33%	-103.21%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.